Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)

Q: What does CUSIP 71722W107 represent in this 13F holders report?

CUSIP 71722W107 is the security identifier for PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q2 2020?

59 institutional investors reported PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q2 2020. Use the holders table for investor-level position and value details.

CUSIP: 71722W107

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 78,837,943
Total 13F shares: 21,847,152
Share change: -101,372
Total reported value: $718,752,879
Price per share: $32.91
Number of holders: 59
Value change: -$3,025,534
Number of buys: 40
Number of sells: 11

Quarterly Holders Quick Answers

What is CUSIP 71722W107?
CUSIP 71722W107 identifies PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 71722W107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FRAZIER MANAGEMENT LLC	13F	Company	9.2%	7,284,269	$188,080,000	—	31 Mar 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	4.7%	3,707,408	$95,725,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	2.6%	2,075,685	$53,594,000	—	31 Mar 2020	13F
Medicxi Ventures Management (Jersey) Ltd	13F	Company	2.6%	2,067,861	$53,392,000	—	31 Mar 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.1%	1,667,577	$42,175,000	—	31 Mar 2020	13F
Abingworth LLP	13F	Company	1.5%	1,203,135	$30,824,000	—	31 Mar 2020	13F
BVF INC/IL	13F	Company	0.86%	676,561	$17,469,000	—	31 Mar 2020	13F
Ensign Peak Advisors, Inc	13F	Company	0.76%	597,492	$15,427,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	0.74%	584,946	$15,104,000	—	31 Mar 2020	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.57%	450,000	$11,619,000	—	31 Mar 2020	13F
Greenspring Associates, LLC	13F	Company	0.46%	360,939	$9,319,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	0.33%	259,343	$6,696,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	0.26%	205,512	$5,306,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	0.24%	187,308	$4,836,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.2%	160,927	$4,155,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.17%	131,258	$3,389,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.09%	68,603	$1,772,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.05%	38,232	$987,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.05%	35,492	$917,000	—	31 Mar 2020	13F
ExodusPoint Capital Management, LP	13F	Company	0.02%	18,765	$485,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.02%	16,700	$431,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	16,629	$429,000	—	31 Mar 2020	13F
FCG ADVISORS, LLC	13F	Company	0.02%	16,300	$421,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	15,743	$406,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.02%	11,948	$308,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	11,423	$295,000	—	31 Mar 2020	13F
HRT FINANCIAL LP	13F	Company	0.01%	10,980	$283,000	—	31 Mar 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	9,700	$250,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.01%	8,008	$207,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0.01%	6,415	$166,000	—	31 Mar 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	6,370	$164,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	6,299	$163,000	—	31 Mar 2020	13F
MetLife Investment Management, LLC	13F	Company	0.01%	5,088	$131,372	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0%	3,710	$96,000	—	31 Mar 2020	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0%	3,587	$92,616	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0%	3,531	$91,000	—	31 Mar 2020	13F
CITIGROUP INC	13F	Company	0%	3,241	$83,000	—	31 Mar 2020	13F
Derivatives Exane	13F	Individual	0%	3,102	$80,090	—	31 Mar 2020	13F
STRS OHIO	13F	Company	0%	2,800	$72,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0%	2,089	$54,000	—	31 Mar 2020	13F
Legal & General Group Plc	13F	Company	0%	1,616	$42,000	—	31 Mar 2020	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	925	$24,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0%	832	$21,000	—	31 Mar 2020	13F
ROYAL BANK OF CANADA	13F	Company	0%	514	$13,000	—	31 Mar 2020	13F
Cutler Group LLC / CA	13F	Company	0%	400	$10,000	—	31 Mar 2020	13F
MEEDER ASSET MANAGEMENT INC	13F	Company	0%	174	$5,000	—	31 Mar 2020	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0%	85	$2,000	—	31 Mar 2020	13F

Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) as of Q2 2020

As of 30 Jun 2020, Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,847,152 shares. The largest 10 holders included FRAZIER MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., Invesco Ltd., Medicxi Ventures Management (Jersey) Ltd, JANUS HENDERSON GROUP PLC, Abingworth LLP, Ensign Peak Advisors, Inc, BlackRock Inc., VANGUARD GROUP INC, and EVENTIDE ASSET MANAGEMENT, LLC. This page lists 59 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.